Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSN-013 (E4/DRSP) in Japanese Women With Dysmenorrhea
jRCT2011210023Completed
- Sponsor
- Fuji Pharma Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of estetrol in dysmenorrhea, endometriosis, adenomyosis and 1 more (2 arms), sponsored by Fuji Pharma Co., Ltd. Primary endpoint: Change in total dysmenorrhea score. Started Aug 2021; status: completed.
02
Drugs
estetrol
03
Conditions
dysmenorrheaendometriosisadenomyosisFibromyoma (LM)
Beyond the preview
Go deeper on jRCT2011210023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011210023.